MTNB
Matinas BioPharma Holdings, Inc.Company with tickers: MTNB
CIK
1582554
CUSIP
576810303
Shares Outstanding
6,406,191
Website
https://www.matinasbiopharma.com
Investor Relations
https://www.matinasbiopharma.com/investors
13F Activity (30d)
3 filings
2 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2022-10-21 | — | |
| 10-Q | 2022-11-02 | 2022-09-30 | |
| 8-K | 2022-11-02 | — | |
| 8-K | 2022-11-14 | — | |
| 8-K | 2022-12-29 | — | |
| 8-K | 2023-01-12 | — | |
| 8-K | 2023-01-30 | — | |
| 10-K | 2023-03-15 | 2022-12-31 | |
| 8-K | 2023-03-15 | — | |
| 8-K | 2023-04-18 | — | |
| 8-K | 2023-05-10 | — | |
| 10-Q | 2023-05-10 | 2023-03-31 | |
| 10-Q | 2023-08-09 | 2023-06-30 | |
| 8-K | 2023-08-09 | — | |
| DEF 14A | 2023-09-19 | — | |
| 8-K | 2023-09-20 | — | |
| 8-K | 2023-09-22 | 2023-09-21 | |
| 8-K | 2023-11-02 | 2023-11-01 | |
| 10-Q | 2023-11-08 | 2023-09-30 | |
| 8-K | 2023-11-08 | — | |
| 8-K | 2023-11-09 | 2023-11-07 | |
| 8-K | 2023-11-20 | — | |
| 8-K | 2023-12-21 | — | |
| 8-K | 2023-12-27 | — | |
| 8-K | 2024-01-09 | — | |
| 8-K | 2024-02-20 | — | |
| 8-K | 2024-02-26 | — | |
| 8-K | 2024-03-22 | — | |
| 8-K | 2024-03-25 | — | |
| 10-K | 2024-03-27 | 2023-12-31 | |
| 8-K | 2024-03-27 | — | |
| 8-K | 2024-03-28 | — | |
| 8-K | 2024-04-05 | 2024-04-02 | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-08-14 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-08-20 | — | |
| 8-K | 2024-08-28 | 2024-08-27 | |
| 8-K | 2024-09-03 | 2024-08-30 | |
| 8-K | 2024-10-24 | 2024-10-23 | |
| 8-K | 2024-10-31 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-27 | — | |
| 8-K | 2025-01-10 | 2025-01-06 | |
| 8-K | 2025-01-24 | 2025-01-21 | |
| 8-K | 2025-02-07 | 2025-02-05 | |
| 8-K | 2025-02-11 | 2025-02-05 | |
| 8-K | 2025-02-13 | — | |
| DEF 14A | 2025-03-03 | — |
Showing 51–100 of 119 filings